• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China.乙型肝炎病毒C1亚基因型基础核心启动子区突变的积累增加了中国南方肝细胞癌的发病风险。
Int J Clin Exp Pathol. 2013 May 15;6(6):1076-85. Print 2013.
2
Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.乙型肝炎病毒核心启动子区突变的序贯积累与中国启东肝细胞癌的发生相关。
J Hepatol. 2008 Nov;49(5):718-25. doi: 10.1016/j.jhep.2008.06.026. Epub 2008 Jul 24.
3
Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.韩国肝细胞癌患者中乙型肝炎病毒C2亚基因型增强子II/核心启动子/前核心区域的特定突变
J Med Virol. 2009 Jun;81(6):1002-8. doi: 10.1002/jmv.21501.
4
Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications.中国的乙型肝炎病毒(HBV)基因型/亚基因型:核心启动子及前核心/核心区的突变及其临床意义
J Clin Virol. 2007 Jun;39(2):87-93. doi: 10.1016/j.jcv.2007.03.005. Epub 2007 Apr 23.
5
Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma.乙型肝炎病毒C1/C2亚基因型增强子II/核心启动子的特定突变会增加肝细胞癌的风险。
J Hepatol. 2006 Nov;45(5):646-53. doi: 10.1016/j.jhep.2006.06.018. Epub 2006 Aug 10.
6
Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.乙型肝炎病毒X和核心启动子突变对C2亚基因型感染患者肝细胞癌的影响
J Clin Microbiol. 2007 Oct;45(10):3191-7. doi: 10.1128/JCM.00411-07. Epub 2007 Jul 25.
7
Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.未治疗的年长基因型 C 中国患者中乙型肝炎病毒基本核心和前核心/核心启动子突变对肝细胞癌的作用。
J Viral Hepat. 2011 Oct;18(10):e423-31. doi: 10.1111/j.1365-2893.2011.01458.x. Epub 2011 Apr 4.
8
Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high risk for hepatocellular carcinoma.个体在高风险 HCC 情况下,HBV 增强子 II 和基本核心启动子中顺序突变的时间获得。
Carcinogenesis. 2011 Jan;32(1):63-8. doi: 10.1093/carcin/bgq195. Epub 2010 Sep 28.
9
Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: a comparison with chronic carriers.乙肝表面抗原阳性肝细胞癌中核心启动子T1762/A1764和前核心A1896基因突变:与慢性携带者的比较
Liver Int. 2007 Dec;27(10):1356-63. doi: 10.1111/j.1478-3231.2007.01585.x. Epub 2007 Sep 26.
10
Viral load, genotypes, and mutants in hepatitis B virus-related hepatocellular carcinoma: special emphasis on patients with early hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌中的病毒载量、基因型和突变体:特别强调早期肝细胞癌患者。
Dig Dis Sci. 2012 Jan;57(1):232-8. doi: 10.1007/s10620-011-1844-2. Epub 2011 Aug 12.

引用本文的文献

1
The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways.乙型肝炎病毒基因组变异在HBV相关肝癌中的作用:对宿主信号通路的影响
Front Microbiol. 2023 Jul 31;14:1213145. doi: 10.3389/fmicb.2023.1213145. eCollection 2023.
2
Establishment and Characterization of an HBV Viral Spread and Infectious System following Long-Term Passage of an HBV Clinical Isolate in the Primary Human Hepatocyte and Fibroblast Coculture System.建立并鉴定了一种 HBV 病毒传播和感染系统,该系统通过在原代人肝细胞和纤维母细胞共培养系统中对 HBV 临床分离株进行长期传代而建立。
J Virol. 2022 Sep 28;96(18):e0084922. doi: 10.1128/jvi.00849-22. Epub 2022 Aug 29.
3
High possibility of hepatocarcinogenesis in HBV genotype C1 infected Cambodians is indicated by 340 HBV C1 full-genomes analysis from GenBank.来自 GenBank 的 340 个 HBV C1 全基因组分析表明,HBV 基因型 C1 感染的柬埔寨人肝癌发生的可能性很高。
Sci Rep. 2019 Aug 21;9(1):12186. doi: 10.1038/s41598-019-48304-z.
4
Association Between HBx Variations and Development of Severe Liver Disease Among Indonesian Patients.印度尼西亚患者中HBx变异与严重肝脏疾病发展之间的关联
Kobe J Med Sci. 2019 Jun 17;65(1):E28-E35.
5
Pseudogene RACGAP1P activates RACGAP1/Rho/ERK signalling axis as a competing endogenous RNA to promote hepatocellular carcinoma early recurrence.假基因 RACGAP1P 作为竞争内源性 RNA 激活 RACGAP1/Rho/ERK 信号轴促进肝癌早期复发。
Cell Death Dis. 2019 Jun 3;10(6):426. doi: 10.1038/s41419-019-1666-2.
6
NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma.NDRG3 过表达与肝癌患者的预后不良相关。
Biosci Rep. 2018 Dec 7;38(6). doi: 10.1042/BSR20180907. Print 2018 Dec 21.
7
The association between hepatitis B mutants and hepatocellular carcinoma: A meta-analysis.乙肝突变体与肝细胞癌之间的关联:一项荟萃分析。
Medicine (Baltimore). 2017 May;96(19):e6835. doi: 10.1097/MD.0000000000006835.
8
HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.乙肝病毒X蛋白(HBx)突变通过Wnt/β-连环蛋白信号通路促进肝癌细胞迁移。
Cancer Sci. 2016 Oct;107(10):1380-1389. doi: 10.1111/cas.13014. Epub 2016 Sep 1.
9
Hepatitis B viral replication influences the expression of natural killer cell ligands.乙型肝炎病毒复制影响自然杀伤细胞配体的表达。
Ann Gastroenterol. 2016 Jul-Sep;29(3):348-57. doi: 10.20524/aog.2016.0036. Epub 2016 Apr 25.
10
HBV X gene point mutations are associated with the risk of hepatocellular carcinoma: A systematic review and meta-analysis.乙肝病毒X基因点突变与肝细胞癌风险相关:一项系统综述和荟萃分析
Mol Clin Oncol. 2016 Jun;4(6):1045-1051. doi: 10.3892/mco.2016.847. Epub 2016 Apr 5.

本文引用的文献

1
Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.乙型肝炎病毒核心启动子区突变的序贯积累与中国启东肝细胞癌的发生相关。
J Hepatol. 2008 Nov;49(5):718-25. doi: 10.1016/j.jhep.2008.06.026. Epub 2008 Jul 24.
2
Effect of basal core promoter and pre-core mutations on hepatitis B virus replication.核心启动子和前核心区突变对乙型肝炎病毒复制的影响。
J Gen Virol. 2008 Apr;89(Pt 4):901-909. doi: 10.1099/vir.0.83468-0.
3
Hepatitis B virus genotypes and subgenotypes in China.中国乙型肝炎病毒基因型和亚型。
Hepatol Res. 2007 Jul;37(s1):S36-41. doi: 10.1111/j.1872-034X.2007.00102.x.
4
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.乙型肝炎病毒增强子II/核心启动子序列变异与肝细胞癌风险之间的时间关系。
Gut. 2008 Jan;57(1):91-7. doi: 10.1136/gut.2006.114066. Epub 2007 May 14.
5
Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels.乙型肝炎病毒B/C基因型、增强子II/核心启动子/前核心区的特定突变以及乙肝病毒DNA水平与肝细胞癌的风险
Gut. 2008 Jan;57(1):98-102. doi: 10.1136/gut.2007.119859. Epub 2007 May 4.
6
Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.肿瘤坏死因子激活一种针对乙肝病毒的保守性固有抗病毒反应,这种反应会使核衣壳不稳定并减少细胞核内的病毒DNA。
J Virol. 2007 Jul;81(14):7351-62. doi: 10.1128/JVI.00554-07. Epub 2007 May 2.
7
Clinical and virological characteristics of hepatitis B virus subgenotypes Ba, C1, and C2 in China.中国乙肝病毒Ba、C1和C2亚基因型的临床及病毒学特征
J Clin Microbiol. 2007 May;45(5):1491-6. doi: 10.1128/JCM.02157-06. Epub 2007 Mar 21.
8
Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma.乙型肝炎病毒C1/C2亚基因型增强子II/核心启动子的特定突变会增加肝细胞癌的风险。
J Hepatol. 2006 Nov;45(5):646-53. doi: 10.1016/j.jhep.2006.06.018. Epub 2006 Aug 10.
9
Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.乙型肝炎病毒前核心/核心启动子突变及血清病毒载量在非肝硬化肝细胞癌中的作用:一项病例对照研究
J Infect Dis. 2006 Sep 1;194(5):594-9. doi: 10.1086/505883. Epub 2006 Jul 18.
10
T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.框α中的T1653突变增加了慢性乙型肝炎病毒C基因型感染患者患肝细胞癌的风险。
Clin Infect Dis. 2006 Jan 1;42(1):1-7. doi: 10.1086/498522. Epub 2005 Nov 29.

乙型肝炎病毒C1亚基因型基础核心启动子区突变的积累增加了中国南方肝细胞癌的发病风险。

Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China.

作者信息

Li Weihua, Chen Guangyuan, Yu Xianwen, Shi Yongying, Peng Miaoguan, Wei Jianjun

机构信息

Department of Infectious Disease, First Affiliated Hospital of Guangzhou Medical College, Guangzhou 510102, Guangdong Province, China.

出版信息

Int J Clin Exp Pathol. 2013 May 15;6(6):1076-85. Print 2013.

PMID:23696925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3657360/
Abstract

UNLABELLED

Hepatitis B virus (HBV) genotype C is associated with the development of hepatocellular carcinoma (HCC). In addition, HBV subgenotype C1 is the major subgenotype in Southern China. The aim of this study was to investigate whether there was the specific mutation patterns in HBV/C1 associated with Southern Chinese patients with HCC.

METHODS

Mutations in HBV basal core promoter (BCP) and their association with HCC were assessed in a matched cross-sectional control study of 102 HCC and 105 chronic hepatitis (CH) patients (from Guangdong, China) infected with HBV/C1. Functional analysis of HBx mutants was performed by the colony formation assay and the luciferase assays.

RESULTS

T1762/A1764 double mutations was frequently found in patients infected with HBV/C1, regardless of clinical status (64.7% in HCC and 51.4% in CH, P>0.05). Unexpectedly, the adjacent V1753 or A1768 mutation significantly increased the risk of HCC (P<0.05). Moreover, the prevalence of triple or quadruple mutations in BCP was significantly higher in patients with HCC than those with CH, particularly for HBeAg-positive-carriers (P<0.05). Functional analysis revealed that T1762/A1764 mutation alone did not alter the transcriptional activity and the inhibitory effects on cell proliferation of HBx, but triple or quadruple mutations largely abrogated this effect.

CONCLUSIONS

Accumulation of mutations involving V1753 or/and A1768 in addition to T1762/A1764 in BCP region were closely related to HCC among the patients infected with HBV/C1, particularly for HBeAg-positive-carriers. The increased risk of HCC caused by BCP variants may be attributable partially to modifying the biological functions of HBx.

摘要

未标记

乙型肝炎病毒(HBV)基因C型与肝细胞癌(HCC)的发生有关。此外,HBV基因C1亚型是中国南方的主要亚型。本研究的目的是调查在中国南方HCC患者中,与HBV/C1相关的特定突变模式是否存在。

方法

在一项匹配的横断面对照研究中,对102例感染HBV/C1的HCC患者和105例慢性肝炎(CH)患者(来自中国广东),评估HBV基础核心启动子(BCP)中的突变及其与HCC的关联。通过集落形成试验和荧光素酶试验对HBx突变体进行功能分析。

结果

无论临床状态如何,感染HBV/C1的患者中经常发现T1762/A1764双突变(HCC患者中为64.7%,CH患者中为51.4%,P>0.05)。出乎意料的是,相邻的V1753或A1768突变显著增加了HCC的风险(P<0.05)。此外,HCC患者BCP中三重或四重突变的发生率显著高于CH患者,尤其是HBeAg阳性携带者(P<0.05)。功能分析表明,单独的T1762/A1764突变不会改变HBx的转录活性和对细胞增殖的抑制作用,但三重或四重突变在很大程度上消除了这种作用。

结论

在感染HBV/C1的患者中,除了BCP区域的T1762/A1764外,涉及V1753或/和A1768的突变积累与HCC密切相关,尤其是对于HBeAg阳性携带者。BCP变异导致的HCC风险增加可能部分归因于改变了HBx的生物学功能。